FOXA and master transcription factors recruit Mediator and Cohesin to the core transcriptional regulatory circuitry of cancer cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Fournier, Michèle ^a,b   Bourriquen, Gaëlle ^a,b   Lamaze, Fabien C ^a,b   Côté, Maxime C ^a,b   Fournier, Éric ^a,b   Joly Beauparlant, Charles ^b   Caron, Vicky ^a,b   Gobeil, Stéphane ^a,b   Droit, Arnaud ^a,b   Bilodeau, Steve ^a,b,c  

^a UNIVERSITÉ LAVAL   (Canada)

^b Université Laval   (Canada)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; COHESIN; FOXA1 PROTEIN, HUMAN; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; MEDIATOR COMPLEX; NONHISTONE PROTEIN;

A-549 CELL LINE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEP-G2 CELL LINE; HUMAN; MCF-7 CELL LINE; METABOLISM; NEOPLASM; PRINCIPAL COMPONENT ANALYSIS; PROMOTER REGION;

A549 CELLS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOMAL PROTEINS, NON-HISTONE; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MCF-7 CELLS; MEDIATOR COMPLEX; NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84991625009     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34962     Document Type: Article

References (60)

1. Spitz, F., Furlong, E. E. M. Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet. 13, 613-626 (2012).
2. Jaenisch, R., Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582 (2008).
3. Graf, T., Enver, T. Forcing cells to change lineages. Nature 462, 587-594 (2009).
4. Morris, S. A., Daley, G. Q. A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res. 23, 33-48 (2013).
5. Davis, R. L., Weintraub, H., Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000 (1987).
6. Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
7. Hochedlinger, K., Jaenisch, R. Induced Pluripotency and Epigenetic Reprogramming. Cold Spring Harb. Perspect. Biol. 7, 1-25 (2015).
8. Lee, T. I., Young, R. A. Transcriptional regulation and its misregulation in disease. Cell 152, 1237-1251 (2013).
9. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005).
10. Thayer, M. J. et al. Positive autoregulation of the myogenic determination gene MyoD1. Cell 58, 241-248 (1989).
11. Zaret, K. S., Mango, S. E. Pioneer transcription factors, chromatin dynamics, cell fate control. Curr. Opin. Genet. Dev. 37, 76-81 (2016).
12. Soufi, A. et al. Pioneer Transcription Factors Target Partial DNA Motifs on Nucleosomes to Initiate Reprogramming. Cell 161, 555-568 (2015).
13. Wang, A. et al. Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates. Cell Stem Cell 16, 386-399 (2015).
14. Carroll, J. S. et al. Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1. Cell 122, 33-43 (2005).
15. Roeder, R. G. Role of General and Gene-specific Cofactors in the Regulation of Eukaryotic Transcription. Cold Spring Harb. Symp. Quant. Biol. 63, 201-218 (1998).
16. Adelman, K., Lis, J. T. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet. 13, 720-731 (2012).
17. Zhou, Q., Li, T., Price, D. H. RNA Polymerase II Elongation Control. Annu. Rev. Biochem. 81, 119-143 (2012).
18. Malik, S., Roeder, R. G. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat. Rev. Genet. 11, 761-772 (2010).
19. Nasmyth, K., Haering, C. H. Cohesin: Its Roles and Mechanisms. Annu. Rev. Genet. 43, 525-558 (2009).
20. Kagey, M. H. et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467, 430-435 (2010).
21. Rahl, P. B. et al. c-Myc regulates transcriptional pause release. Cell 141, 432-445 (2010).
22. Smith, E., Shilatifard, A. Enhancer biology and enhanceropathies. Nat. Struct. Mol. Biol. 21, 210-219 (2014).
23. Zhang, X. et al. Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. Nat. Genet. 48, 176-182 (2016).
24. Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455-461 (2014).
25. Hnisz, D. et al. Super-Enhancers in the Control of Cell Identity and Disease. Cell 155, 934-947 (2013).
26. Lovén, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320-334 (2013).
27. Gonda, T. J., Ramsay, R. G. Directly targeting transcriptional dysregulation in cancer. Nat. Rev. Cancer 15, 686-694 (2015).
28. Losada, A. Cohesin in cancer: chromosome segregation and beyond. Nat. Rev. Cancer 14, 389-393 (2014).
29. Spaeth, J. M., Kim, N. H., Boyer, T. G. Mediator and human disease. Semin. Cell Dev. Biol. 22, 776-787 (2011).
30. Wendt, K. S. et al. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 451, 796-801 (2008).
31. Parelho, V. et al. Cohesins Functionally Associate with CTCF on Mammalian Chromosome Arms. Cell 132, 422-433 (2008).
32. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
33. Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43-49 (2011).
34. Wang, H. et al. Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res. 22, 1680-1688 (2012).
35. Liu, Z. et al. Enhancer Activation Requires trans-Recruitment of a Mega Transcription Factor Complex. Cell 159, 358-373 (2014).
36. Odom, D. T. et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378-1381 (2004).
37. Burakov, D., Wong, C. W., Rachez, C., Cheskis, B. J., Freedman, L. P. Functional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex. J. Biol. Chem. 275, 20928-20934 (2000).
38. Maeda, Y. et al. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Mol. Endocrinol. 16, 1502-1510 (2002).
39. Malik, S., Wallberg, A. E., Kang, Y. K., Roeder, R. G. TRAP/SMCC/Mediator-Dependent Transcriptional Activation from DNA and Chromatin Templates by Orphan Nuclear Receptor Hepatocyte Nuclear Factor 4. Mol. Cell. Biol. 22, 5626-5637 (2002).
40. Li, W. et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498, 516-520 (2013).
41. Wallerman, O. et al. Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing. Nucleic Acids Res. 37, 7498-7508 (2009).
42. Alder, O. et al. Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation. Cell Rep. 9, 261-271 (2014).
43. Shu, J. et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 153, 963-975 (2013).
44. Pomerantz, M. M. et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat. Genet. 47, 1346-1351 (2015).
45. Hurtado, A., Holmes, K. a, Ross-Innes, C. S., Schmidt, D., Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43, 27-33 (2011).
46. Wang, J. et al. FOSL2 Positively Regulates TGF-1 Signalling in Non-Small Cell Lung Cancer. PLoS One 9, e112150 (2014).
47. Tang, Y., Shu, G., Yuan, X., Jing, N., Song, J. FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-tomesenchymal transition in human lung cancers. Cell Res. 21, 316-326 (2011).
48. Mullen, A. C. et al. Master transcription factors determine cell-type-specific responses to TGF-signaling. Cell 147, 565-576 (2011).
49. Liu, J., Krantz, I. D. Cohesin and human disease. Annu. Rev. Genomics Hum. Genet. 9, 303-320 (2008).
50. Solomon, D. a. et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333, 1039-1043 (2011).
51. Xu, H., Tomaszewski, J. M., McKay, M. J. Can corruption of chromosome cohesion create a conduit to cancerNat. Rev. Cancer 11, 199-210 (2011).
52. Mäkinen, N. et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334, 252-255 (2011).
53. Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012).
54. Maurano, M. T. et al. Large-scale identification of sequence variants influencing human transcription factor occupancy in vivo. Nat. Genet. 47, 1393-1401 (2015).
55. Bilodeau, S., Kagey, M. H., Frampton, G. M., Rahl, P. B., Young, R. A. SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev. 23, 2484-2489 (2009).
56. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
57. Quinlan, A. R., Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
58. Tiscornia, G., Singer, O., Verma, I. M. Production and purification of lentiviral vectors. Nat. Protoc. 1, 241-245 (2006).
59. Oster, S. K., Mao, D. Y. L., Kennedy, J., Penn, L. Z. Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene 22, 1998-2010 (2003).
60. Pan, Y. F. et al. Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements. J. Biol. Chem. 283, 32977-32988 (2008).